Cargando…
Fibrinogen Replacement Therapy for Traumatic Coagulopathy: Does the Fibrinogen Source Matter?
Fibrinogen is the first coagulation protein to reach critically low levels during traumatic haemorrhage. There have been no differential effects on clinical outcomes between the two main sources of fibrinogen replacement: cryoprecipitate and fibrinogen concentrate (Fg-C). However, the constituents o...
Autores principales: | Morrow, Gael B., Carlier, Molly S. A., Dasgupta, Sruti, Craigen, Fiona B., Mutch, Nicola J., Curry, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926643/ https://www.ncbi.nlm.nih.gov/pubmed/33671748 http://dx.doi.org/10.3390/ijms22042185 |
Ejemplares similares
-
Fibrinogen replacement in trauma haemorrhage
por: Curry, Nicola, et al.
Publicado: (2014) -
Changes in fibrinogen availability and utilization in an animal model of traumatic coagulopathy
por: Hagemo, Jostein S, et al.
Publicado: (2013) -
Is fibrinogen the answer to coagulopathy after massive transfusions?
por: Tisherman, Samuel A
Publicado: (2010) -
Fibrinogen in dilutional coagulopathy: a dose study in pigs
por: Martini, J, et al.
Publicado: (2010) -
Pediatric Fibrinogen PART I—Pitfalls in Fibrinogen Evaluation and Use of Fibrinogen Replacement Products in Children
por: Huisman, Elise J., et al.
Publicado: (2021)